A, C., R, M., D, K., M, P., S, P., B, F., . . . A, F. (2026). Intranasal esketamine in treatment-resistant depression: Long-term dosing patterns and clinical outcomes in a 5-year observational study. Therapeutic advances in psychopharmacology, 16, 20451253261437597. https://doi.org/10.1177/20451253261437597
Παραπομπή σε μορφή Chicago (17η εκδ.)A, Cuomo, et al. "Intranasal Esketamine in Treatment-resistant Depression: Long-term Dosing Patterns and Clinical Outcomes in a 5-year Observational Study." Therapeutic Advances in Psychopharmacology 16 (2026): 20451253261437597. https://doi.org/10.1177/20451253261437597.
Παραπομπή σε μορφή MLA (9th εκδ.)A, Cuomo, et al. "Intranasal Esketamine in Treatment-resistant Depression: Long-term Dosing Patterns and Clinical Outcomes in a 5-year Observational Study." Therapeutic Advances in Psychopharmacology, vol. 16, 2026, p. 20451253261437597, https://doi.org/10.1177/20451253261437597.